T1	Participants 444 557	Ninety-nine eligible patients with T2 to T4b transitional cell bladder cancer participated, 64% with cT3b or cT4.
T2	Participants 558 657	Patients and their physicians selected either definitive radiotherapy or precystectomy radiotherapy
T3	Participants 1949 1967	distant metastases
